Clinical Trials Browser

Interventional × Neoplasms × ixazomib × Clear all

NCT03590652 2025-10-21

Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone as Salvage Therapy in Relapsed/Refractory Multiple Myeloma

Phase 2 Terminated

Multiple Myeloma, Neoplasms

NCT03422874 2018-02-06

Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma

Phase 1 Withdrawn

Lymphoma, Neoplasms